CIM
REGN icon

Calvert Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Calvert Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,592
Closed -$1.69M – 472
2016
Q4 		$1.69M Sell
4,592
-162
-3% -$61.6K 0.06% 312
2016
Q3 		$1.91M Buy
4,754
+87
+2% +$34.9K 0.07% 299
2016
Q2 		$1.63M Buy
4,667
+182
+4% +$70.1K 0.07% 277
2016
Q1 		$1.62M Buy
4,485
+458
+11% +$189K 0.07% 251
2015
Q4 		$2.19M Buy
4,027
+840
+26% +$455K 0.1% 191
2015
Q3 		$1.48M Buy
3,187
+160
+5% +$85.9K 0.07% 176
2015
Q2 		$1.54M Sell
3,027
-260
-8% -$127K 0.07% 187
2015
Q1 		$1.48M Buy
3,287
+323
+11% +$137K 0.1% 185
2014
Q4 		$1.22M Buy
2,964
+255
+9% +$100K 0.08% 199
2014
Q3 		$977K Buy
2,709
+1,955
+259% +$655K 0.07% 206
2014
Q2 		$213K Hold
754
– – 0.01% 334
2014
Q1 		$226K Buy
754
+1
+0.1% +$308 0.02% 321
2013
Q4 		$207K Hold
753
– – 0.02% 324
2013
Q3 		$236K Buy
+753
New +$198K 0.03% 283

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Calvert Investment Management's REGN Position: Q1 2017 in Review

Calvert Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 4,592 shares — an estimated $1.69M sold.

Calvert Investment Management first reported a position in REGN in Q3 2013 and held it in 14 quarters. The position peaked at $2.19M in Q4 2015. 578 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • Calvert Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 4,592 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $1.69M.
  • Calvert Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 14 quarters.
  • Calvert Investment Management's Regeneron Pharmaceuticals position peaked at $2.19M in Q4 2015.
  • 578 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.